Back
Chevron Corp. 10K Form
Buy
55
CVX
Chevron Corp.
Last Price:
$183.68
Seasonality Move:
5.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-07-15 | 10K | CVX/Chevron Corp. Annual |
| 2025-06-15 | 10K | CVX/Chevron Corp. Annual |
| 2025-05-15 | 10K | CVX/Chevron Corp. Annual |
| 2025-04-15 | 10K | CVX/Chevron Corp. Annual |
| 2025-03-15 | 10K | CVX/Chevron Corp. Annual |
| 2025-02-15 | 10K | CVX/Chevron Corp. Annual |
Receive CVX News And Ratings
See the #1 stock for the next 7 days that we like better than CVX
CVX Financial Statistics
Sales & Book Value
| Annual Sales: | $184.4B |
|---|---|
| Cash Flow: | $5.4B |
| Price / Cash Flow: | 20.53 |
| Annual Sales: | $94.28 |
| Price / Book: | 1.92 |
Profitability
| EPS (TTM): | 6.65100 |
|---|---|
| Net Income (TTM): | $12.5B |
| Gross Margin: | $21.6B |
| Return on Equity: | 7.5% |
| Return on Assets: | 4.41% |
Chevron Corp. Earnings Forecast
Key Chevron Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for CVX is 11.71%.
-
The Selling, General & Administrative Expenses for CVX have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.18% of Revenue.
-
The Interest Expense is 9.75% of Operating Income.
-
The Net Earning history of CVX is 6.77% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 21 years.
Chevron Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | CVX |
| CUSIP: | 166764 |
| Website: | chevron.com |
Debt
| Debt-to-Equity Ratio: | 0.22 |
|---|---|
| Current Ratio: | 1.15 |
| Quick Ratio: | 0.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.71 |
|---|---|
| Forward P/E Ratio: | 20.05 |
CVX Technical Analysis vs Fundamental Analysis
Buy
55
Chevron Corp. (CVX)
is a Buy
Is Chevron Corp. a Buy or a Sell?
-
Chevron Corp. stock is rated a BuyThe current Chevron Corp. [CVX] share price is $183.74. The Score for CVX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.